Case Reports in Ophthalmology · 2020 · 18 citations · 7 references
MedicineOncologyOphthalmologyImmunotherapyOcular DiseaseOcular ImmunologyMacular DiseaseMacular DisordersRetinal DiseaseRetinal Vascular DiseaseDrug-induced Ocular ToxicityInflammatory Retinal VasculitisMacular Edema TreatmentMacular ToxicityRetinal Vasculopathy
Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, the retinal vasculitis resolved and macular edema improved during follow-up. There was no need for durvalumab to be withdrawn.
7